Dr. Sam Azoulay is the Senior Vice President, Medical & Development, of the Emerging Markets and Established Products Business Units for Pfizer Inc. Dr. Azoulay joined Pfizer as a result of the company’s acquisition of Parke Davis, Warner Lambert in 2000, where h…more ›

Dr. Berthold Bödeker is Chief Scientist and heading pilot plants and cell culture at the CMC unit of Global Drug Discovery-Biological Development of Bayer Schering Pharma AG in Wuppertal, Germany, which is responsible for the technical development and clinical mate…more ›

Dr. Bücheler joint Boehringer Ingelheim (formerly Dr. Karl Thomae GmbH) in 1991. During his time at Boehringer Ingelhein he held different positions in Biopharmaceuticals like regulatory affairs, Validation, CMC/GMP documentation and biological safety. For several …more ›

Dr. Wei-Kuang Chi, Vice President and Director of CGMP Biopharmaceutical Pilot Plant Facility, Development Center for Biotechnology (DCB) obtained his M.S in Engineering and Ph.D. in Chemical Engineering from the University of Pennsylvania, Philadelphia, USA. Dr. Chi …more ›

In his role as Vice President, BioProcess R&D NA at sanofi pasteur, Dr. D?Amore provides leadership to a Division of over 100 people and contributes to the growth and profitability of the Company through the overall direction, administration and management of all ac…more ›

Dr. Gottschalk is Group Vice President, Purification Technologies, with a global responsibility for bioseparation products at Sartorius Stedim Biotech. He worked in different capacities for Bayer Health Care from 1991-2004 and became head of the GMP protein purification…more ›

Bernhard Helk is Global Executive Director of Technology Development at Novartis Biologics/Process Sciences. He received a masters degree in Pharmaceutical Sciences from University of Erlangen/Germany and a Ph. D. in Biochemistry from University of Bayreuth/Germany. He …more ›

Chandrakant Kathote is Senior Director of Manufacturing at Biocon Limited and is responsible for the manufacturing operations of microbial fermentation based products at Biocon Limited. He has over 14 years of Industry experience with various fermentation derived produc

Dr. Christian Leist is the head of the Bioprocess Development Group in the Department of Biotechnology Development at Novartis Pharma Ltd in Basel and is also responsible for the development and implementation of related new key technologies. After attaining his master…more ›

Jason has over 15 years of experience in the Biotechnology Industry and more than 10 years of that was spent on the Development and manufacturing of biopharmaceuticals in U.S., such as Global Process Engineering in Amgen and Process Development in Invitrogen. The produc…more ›

Svend Licht is global head of Sales & Business development in Novozymes Biopharma with responsibility for commercialisation of technologies, products and solutions to the biopharmaceutical industry. He joined Novo in 1986. In 1994 he went to Paris as sales support …more ›

Dr Wassim Nashabeh received his Ph.D. in Analytical Chemistry from Oklahoma State University in 1993, and his post-doctoral fellowship from ?Barnett Institute of Chemical and Biological Analysis? at Northeastern University where he developed new approaches for the separ…more ›

Dr. Ulrich Rümenapp is the Head of Biotech Projects in Contract Manufacturing Biotech at Bayer Schering Pharma AG, providing team leadership, manufacturing process and project management expertise to ensure reliability in supply, quality and economy of costs for pr…more ›

Dr. Serckx-Poncin holds a PhD in Organic Chemistry. After spending a few years in research at University, Dr Serckx-Poucin moved to the Pharmaceutical Industry where she joined GSK-Pharma and then Cardinal Health, a US contract manufacturer. She has a wide pharmaceutic…more ›

Dr. Tahiliani has more than 15 years of academic and Industrial experience in Life Science research and biotech process development. Currently, he is responsible for technology positioning to help facilitate process development with improved process economics in Pall Li…more ›

Dr. Wu Ke is the President of BravoBio. He has 23 years of experiences in biopharm industry and has successfully developed 7 products approved by SFDA and marketed in China. Dr. Wu was Executive President of Shanghai Zerun Biotechnology, Wison Group, in charge of manag…more ›